An exploratory study on outsourcing of clinical trials by pharmaceutical companies to contract research organisations in nontraditional
trial regions.

Clinical research is an important aspect of universalising healthcare, enabling the development of better drugs, tests, vaccines, devices, surgical procedures and other medical interventions and protocols for their safer and more rational use. However, today it is viewed merely as a business investment with high returns.

This report is the product of a journalistic investigation on clinical trials. It set out to identify ethical concerns in clinical trials that were conducted in India and used for approval of new drugs in the European Union (EU).